Skip directly to content

Pfizer at EuCongress Twitter Community Guidelines

These are the Pfizer at EuCongress (@PfizerCongress) Twitter Feed Community Guidelines. We have set up this Twitter account to share news and information with healthcare professionals about Pfizer activities at medical conferences held in Europe.

We have created some house rules to ensure compliance with the regulations of our industry, our own standards and the Terms of Use of Twitter.

  1. By following Pfizer at EuCongress (@PfizerCongress) you confirm that you are a healthcare professional and agree to receive information relating to educational and promotional activities supported or organised by Pfizer.
     
  2. Please remember that your access to any social media channel is governed by its specific Terms of Service. Pfizer Ltd fully endorses the Terms of Service of all the social media services it uses and it is important that you abide by them. As such, we reserve the right to report tweets that we believe are in breach of the general Twitter rules (https://support.twitter.com/articles/18311).
     
  3. By following Pfizer Ltd on any social media service, you acknowledge that you have read, understood and agreed to our House Rules and Twitter’s Terms of Service (https://support.twitter.com/articles/18311). We reserve the right to block followers if they do not comply with those Terms.
     
  4. At Pfizer Ltd, we are mindful of important regulations that govern our industry and so we ask our followers not to post any information about medicines. If you have any questions about a specific Pfizer medication (bearing the Pfizer logo), please contact your local Pfizer Medical Information.  For contact details of Pfizer Medical Information by country, please see table below.  For all UK Pfizer Medical Information queries/questions, please contact Pfizer on 01304 616161.
     
  5. Given the serious implications that unsolicited and unverified medical advice might have, please do not post medical advice of any nature. Any such advice should not be acted on in the absence of, and is not a substitute for, advice provided by a doctor or other qualified healthcare professional.
     
  6. Pfizer Ltd social media accounts are public so please be aware that your posts will be deemed non-confidential and will be available for unrestricted viewing. By posting your content within the @PfizerCongress Twitter account you acknowledge that Pfizer Ltd shall be entitled to use those posts for free, without any time limit and for any purpose whatsoever.
     
  7. To protect your privacy, and the privacy of others, please do not include personally identifiable information about yourself or any other person, such as phone numbers, email addresses, information about your health or any disease you encountered or other personal information in any comments posted to our social media channels.
     
  8. We do not intend to store your Twitter profile unique ID, email or other personal details. However, in cases where you inform us of an adverse event or product issue we may need to store information about you, such as your name or location. This information is required by regulatory authorities and by the Pfizer Drug Safety department.
     
  9. The views and opinions expressed by any of our followers are not those of Pfizer. Where applicable, we follow other social media accounts relevant to our work at our discretion. Twitter accounts that Pfizer at EuCongress (@PfizerCongress) follows or is followed by are not an indication of our endorsement of these accounts or the content they produce.
     
  10. Please treat all fellow service users with respect and please do not publish any comments that could be perceived as offensive, unsuitable or derogatory. We are not legally responsible for content posted by third parties. We will not respond to any post that contains vulgarity (including imagery) or offensive language, is disparaging, threatening, or condones illegal behaviour. In addition, we will not respond to personal attacks of any kind or offensive terms that target specific ethnic, racial, religious, age or gender orientation groups.
     
  11. You will remain solely responsible for the contents you post and you will hold Pfizer harmless from any consequence and prejudice that may arise against Pfizer in respect of your posted contents in breach of our House Rules and/or Twitter’s Terms of Service (https://support.twitter.com/articles/18311).
     
  12. We welcome the opportunity to hear from you via Twitter mentions and replies and we will be actively monitoring the channel. Where the need arises we will respond to your tweets and/or direct messages but we will not reply individually to all messages received. We would like to remind you that we work in a regulated industry with a unique legal situation in healthcare. As such, we cannot engage in sensitive topics, or discussion(s) about products (ours or other companies’) or treatment options on Twitter. Please note that we may not be able to respond to an @mention or reply to a tweet that:
    1. Does not come from a health professional. All tweets are intended for European-based healthcare professionals.
    2. Mentions a medicinal product (ours or someone else’s). If your post references a product/brand from any company – positive or negative – we may not be able to respond to it as we have to be mindful of the important regulations that govern our industry and the need to provide balanced information about our products in a consistent manner. It is illegal for us to promote medicinal products to the general public in Europe. We may ask that you delete or amend your comment accordingly, or we may delete our tweet and thus any associated comments.
    3. Mentions a possible side effect. If your post includes reference to possible side effects associated with a Pfizer product, we may be required to contact you for further information and request consent to collect additional information as we will need to fulfil legal obligations concerning drug safety reporting.  Adverse events should be reported.  You can contact us to report an adverse event related to our products by contacting Pfizer Medical Information (contact details by country are in the table at the foot of this page). UK adverse events should also be reported via the Yellow Card Scheme (www.mhra.gov.uk/yellowcard).
    4. Contains Medical Advice. Given the serious implications unsolicited and unverified medical advice might have, we can’t condone it on our Twitter feed and may delete our tweet to remove any such comments. As always, we recommend consulting with a qualified physician about any medical condition.
    5. Is Off-Topic. Sometimes comments are clearly off topic, spam, make unsupported accusations, disrupt the community or promote services or products. We will not respond to these.
    6. Is not written in English. Our Twitter feed is English speaking only and as such any non-English tweets may not be responded to.
       
  13. Pfizer Ltd will use reasonable efforts to include accurate information on our accounts but gives no warranties, undertakings or representations of any kind as to its accuracy, currency, quality, completeness or fitness for purpose. Any information provided by Pfizer and/or made available through our social media accounts is provided on an “as is” basis. Pfizer disclaims all warranties, express or implied to the full extent permitted by law. Pfizer shall be not liable for any loss, damage or cost whatsoever, whether in contract, tort (including negligence) or otherwise arising from reliance on information posted on our social media accounts. This limitation includes any loss, damage or cost caused by any viruses that infect your computer equipment, software or data.
     
  14. Where links are posted to third party websites maintained by third parties over which Pfizer Ltd has no control, Pfizer Ltd is not responsible for the content of those websites. Any links to third party websites posted on the Pfizer Ltd social media accounts do not amount to any endorsement of that website by Pfizer Ltd and any use of that website by you is at your own risk.
     
  15. We may alter our House Rules from time to time, so you should periodically check this page as any changes will take effect as soon as they are posted to our website (www.pfizer.co.uk).
     
  16. To the extent that any provisions of these House Rules are held to be illegal, invalid or unenforceable, then such provisions shall be severed and deleted without affecting the enforceability of the remaining provisions.
     
  17. These community guidelines shall be governed by and construed in accordance with the laws of England and Wales. The English courts shall have exclusive jurisdiction over any disputes arising in connection with the Pfizer Twitter account.

 

COUNTRY

EMAIL

FAX N°

PHONE/ADDITIONAL DETAILS
(Phone n°NOT for clinical study AE reporting

Algeria
(under responsibility of Morocco)

DZA.AEReporting@pfizer.com

Toll-Free (local): N/A

Alt.1: +213 21 89-1126

Tel.: +213 21 89-1102 to 08 (Algeria switchboard office hours)

Tel.: +213 2189-1128
(Algeria PCO 24/7)

Tel.: +212 522 79-1957
(Morocco switchboard 24/7)

Fax: +212 522 79-1984 (Morocco)
Cell: +212 661 20-1214 (EL KABAILI Marouane - Morocco)

Argentina
Paraguay, Uruguay

ARG.AEReporting@pfizer.com

Toll-Free (local): 0800444-4512

Alt. 1: +54 11 4788-7003

Alt. 2: +1 973-660-8966

Tel.: +54 11 4787-8290

Australia
New Zealand (See New Zealand) and Oceania (Cook Islands, East Timor, Federated States of Micronesia, Fiji, Kiribati, Niue, Palau, Papua new Guinea, Samoa, Solomon Islands, Tuvalu and Vanuatu)

AUS.AEReporting@pfizer.com

Toll-Free (local): 180003-4314
(Australia ONLY)

Alt. 1: +1 973-660-8913

Adverse Event Reports:
Tel.: 1800 734260
(Australia ONLY)

Austria

AUT.AEReporting@pfizer.com

Toll-Free (local): N/A

Alt. 1: +43 1 524-4023

Adverse Event Reports:
Tel.: +43 1 52115-840
(Sulzbacher, Ulrike);

+43 1 52115-144
(Miyama, Kenta)

Belarus
(under responsibility of  Russia)

RUS.AEReporting@pfizer.com

Toll-Free (local): 88200011-0315

Alt. 1:  +1 973-660-8965

Tel.: +375 17 309-3800

Tel.: +7 495 287-5343;

Cell: +7 985 222-6145
(Prokhorova, Tatyana)

Belgium
Luxembourg  (see Luxembourg)

BEL.AEReporting@pfizer.com

Toll-Free (local): 08007-8614

Alt. 1:  +1 973-660-8914

Tel.: +32 2 554-6060

Brazil

BRA.AEReporting@pfizer.com

Toll-Free (local): 0800-020-3461

Alt. 1:  +1 973-660-8916

Adverse Event Reports:
Tel.: +55 11 5185-3787
(Forcato Vida, Cássia)

Tel.: +55 11 5185-8548
(Pasin, Cristiane O.)

Bulgaria

BGR.AEReporting@pfizer.com

Toll-Free (local):  00800118-1183

Alt. 1:  +1 973-660-8915

Tel.:+359 2 970-4233;

Cell:+359 88415-3412 (Kazandzhieva, Anzhela)

Canada

CAN.AEReporting@pfizer.com

Toll-Free (local): 1855 242-5652

Alt. 1:  +1 973-660-8917

Tel.: 1866 723-7111 (toll-free)
Pfizer Canada employees - tel. extension 6828

Chile

CHL.AEReporting@pfizer.com

Toll-Free (local): 1230020-9286

Alt.1: +562 2241-2021

Alt. 2:  +1 973-660-8919

Tel.: +562 2241 -2109

China

CHN.AEReporting@pfizer.com

Toll-Free (local): 10800714-1806 (north)

Toll-Free (local): 10800140-1838 (south)

Alt. 1:  +1 973-660-8920

Tel.: 400 066-5025

Colombia
Venezuela (See Venezuela)

COL.AEReporting@pfizer.com

Toll-Free (local): 01800518-2633

Alt. 1:  +1 973-660-8921

Cell: +57 311 561-9615 (24h line)

Costa Rica (Central America)
Anguilla, Antigua, Aruba, Bahamas, Barbados, Belize, Bermuda, Cayman Islands, Curaçao, Dominica, Dominican Repuplic, El Salvador, Grenada, Guatemala, Guyana, Jamaica,  Haiti, Honduras, Montserrat, Nicaragua, Panama, St Lucia, St Kitts and Nevis, St Maarten, St Vincent, Suriname, Trinidad and Tobago, Turks and Caicos    

 

CRI.AEReporting@pfizer.com

Toll-Free (local): N/A

Alt.1: +506 2201-5680

Tel.: +506 2208-9509

Cell: +506 7071-2185
(Duarte, Betty)

Côte d’Ivoire
Benin, Burkina Faso, Burundi, Cape Verde, Cameroon, Central African Republic, Chad, Congo, Democratic Republic of Congo, Gabon, Gambia, Guinea, Guinea Bissau, Guinée Equatoriale and Djibouti, Liberia, Mali, Mauritania, Niger, Rwanda, Sao Tome and Principe, Senegal, Sierra Leone, Togo

CIV.AEReporting@pfizer.com

Toll-Free (local): N/A

Alt.1: +225 22 48-6303

Tel.: +225 22 48-3730
(Ezechiel, N'dri)

Croatia
Bosnia & Herzegovina   

HRV.AEReporting@pfizer.com

Toll-Free (local): 0800-9601

Alt.1:  +385 1 390-8789

Alt. 2:  +1 973-660-8932

Tel.: +385 1 390-8788;

Cell: +385 91 370-7064
(Bacic, Julija)

Back-up contact n°s:
Tel.: +386 1 586-3232;

Cell: +386 40 18-8912
(Kastelec, Natasa)

Czech Republic

CZE.AEReporting@pfizer.com

Toll-Free (local): 80050-0332

Alt. 1:  +1 973-660-8964

Tel.: +420 28300-4111
(Pfizer switchboard)

Denmark
Iceland

DNK.AEReporting@pfizer.com

Toll-Free (local): 80250953
Alt.1: +45 4420-1161

Alt. 2:  +1 973-660-8923

Tel.: +45 4420-1100
(Pfizer switchboard); 

Cell: +45 2920-3209

Egypt
Sudan, South Sudan

EGY.AEReporting@pfizer.com

Toll-Free (local): 0800000-0690

Alt. 1:  +1 973-660-8924

Tel.: +20 2 3333-7777
(Pfizer switchboard)

Tel.: +20 2 3333-7751;

Cell : +20 1 00017-2125
(Kamel, Amira)

Estonia
(under responsibility of  Lithuania)

EST.AEReporting@pfizer.com

Toll-Free (local): 800010-0425

Alt. 1:  +1 973-660-8926

Tel.: +372 666-7500
(Pfizer switchboard)

Finland

FIN.AEReporting@pfizer.com

Toll-Free (local): 080091-5687

Alt. 1:  +1 973-660-8927

Tel.: +358 9 43-0040
(Pfizer switchboard, voice mail after office hours)

France
Monaco, Guyane, Guadeloupe, Martinique, Réunion, Saint-Pierre et Miquelon, Tahiti, Wallis-et-Futuna

FRA.AEReporting@pfizer.com

Toll-Free (local): 080091-1463

Alt.1: +33 1 72 26-5770

Alt. 2:  +1 973-660-8928
(Non Clinical Trial reports)

Toll: +33 1 70 74 57 33
(Clinical Trial reports)

Tel: 080039-8450 (toll-free)

Tel: +33 1 58 07-3389

Germany

DEU.AEReporting@pfizer.com

Toll-Free (local): 0800183-0898

Alt. 1:  +1 973-660-8922

 

Ghana
(under responsibility of Nigeria)

NGA.AEReporting@pfizer.com

Toll-Free (local): N/A

Alt.1: N/A

Tel: +233 30 276-3513
(Pfizer Ghana, Reception Desk)

Greece
Malta, Cyprus

GRC.AEReporting@pfizer.com

Toll-Free (local): 008001612206-4512

Alt.1: +30 210 819-9096

Alt. 2:  +1 973-660-8930

Tel.: +30 210  678-5908
(office hours); 

+30  210 678-5808
(24h line)

Hong Kong
Macao

HKG.AEReporting@pfizer.com

Toll-Free (local): 80096-5423

Alt. 1:  +1 973-660-8931

Cell: +852 9863-0271; 

+852 9863-9817
(Drug Safety Unit)

Hungary

HUN.AEReporting@pfizer.com

Toll-Free (local): 068010-9879

Alt. 1:  +1 973-660-8933

Cell: +36-30-383-8906
(24h line)

Tel.: +36-1-488-3730
(Tege, Antónia)

India
Bangladesh, Bhutan, Maldives, Nepal, Pakistan (See Pakistan), SriLanka

IND.AEReporting@pfizer.com

Toll-Free (local):  000800100-5961

Alt.1:  +91 22 3919-7714

Alt. 2:  +1 973-660-8935

Tel.: +91 22 6693-2208

Indochina (under responsibility of Thailand)
Myanmar,  Cambodia, Laos, Vietnam Nutrition products

THA.AEReporting@pfizer.com

Toll-Free (local): N/A

Alt.1:  +66 2 665-4828

Cell: +66 81 623-8429 (Safety Hotline Cell Phone)

Indonesia

IDN.AEReporting@pfizer.com

Toll-Free (local): 001803019-4512

Alt. 1:  +1 973-660-8934

Tel.: +62 21 5793-1088

Cell: +62 8 1617 911-911
(Safety Hotline Cell Phone)

Ireland (under responsibility of  United Kingdom)

GBR.AEReporting@pfizer.com

Toll-Free (local): 180094-8803

Alt. 1:  +1 973-660-8929

Tel.: 1800 63-3363 (toll-free)

Israel
Palestine

ISR.AEReporting@pfizer.com

Toll-Free (local): 180945-4512

Alt.1: +972 9 970-0544

Alt. 2:  +1 973-660-8936

Cell: +972 50 708-9358
(Kand, Michael)

Tel.: +972 9 970-0154

Italy
San Marino, Vaticano

ITA.AEReporting@pfizer.com

Toll-Free (local): 80087-4213

Alt. 1:  +1 973-660-8937

Tel.: +39 06 331-82999

Japan

JPN.AEReporting@pfizer.com

Toll-Free (local): 120 44-2370

Alt. 1:  +1 973-660-8963

 

Korea

KOR.AEReporting@pfizer.com

Toll-Free (local): 0079814206-4512

Alt.1: +82 2 317-2135

Alt. 2:  +1 973-660-8938

Tel.: +82 2 317-2146
(office hours); 

82 10 8771-7114
(24 hours)

Latvia (under responsibility of  Lithuania)

LVA.AEReporting@pfizer.com

Toll-Free (local): 8000-4584

Alt. 1:  +1 973-660-8940

Tel.: +371 6703-5775
(Pfizer Latvia switchboard)

Lithuania
Estonia, Latvia (See Estonia, Latvia)

LTU.AEReporting@pfizer.com

Toll-Free (local):  88003-1617

Alt. 1:  +1 973-660-8939

Tel.: +370 5 251-4000; 

Cell: +370 698-86901
(Streikuvienė, Irena)

Luxembourg
(under responsibility of  Belgium)

BEL.AEReporting@pfizer.com

Toll-Free (local): 8002-6191

Alt. 1:  +1 973-660-8914

Tel.: +32 2 554-6060

Malaysia
Brunei

MYS.AEReporting@pfizer.com

Toll-Free (local):180081-6432

Alt.1: +60 3 2281-6384

Alt. 2:  +1 973-660-8942

Cell: +60 12 341-7896
(Safety Hotline Cell Phone)

Mexico

MEX.AEReporting@pfizer.com

Toll-Free (local): 01800228-4627

Alt.1:  +52553692-4892

Alt. 2:  +1 973-660-8941

Toll-Free: 01800401-2002

Morocco
Algeria (See Algeria)

MAR.AEReporting@pfizer.com

Toll-Free (local): N/A

Alt.1: +212 522 79-1984

Tel.: +212 522 791-957
(Morocco switchboard 24/7)

Cell: +212 661 20-1214
(EL KABAILI Marouane - Morocco)

Netherlands (The)

NLD.AEReporting@pfizer.com

Toll-Free (local): 0800022-1301

Alt.1: +31 10 406-4393

Alt. 2:  +1 973-660-8943

Tel.: +31 10 406-4290

New Zealand
(under responsibility of Australia)

AUS.AEReporting@pfizer.com

Toll-Free (local): 080044-0739

Alt. 1:  +1 973-660-8913

Adverse Event Reports:
Tel.:  0800 734 260

Nigeria
Nigeria and East Africa Region (Anglophone Countries)  Angola, Comoros, Eritrea, Ethiopia, Ghana, Kenya, Nigeria, Somalia, Tanzania, Uganda

NGA.AEReporting@pfizer.com

Toll-Free (local): N/A

Alt.1: N/A

Tel:  +234 1 44-83742

Tel:  +234 1 270-3921-5  ext 83742,

Cell: +234 808 750-5459
(Fadaka, Eseoghene)

Norway

NOR.AEReporting@pfizer.com

Toll-Free (local): 8006-9969

Alt. 1:  +1 973-660-8944

Tel.: +47 6 752-6100

Pakistan  (under responsibility of India)
Afghanistan

IND.AEReporting@pfizer.com

Toll-Free (local): N/A

Alt.1: +9221 3233-1049

Alt. 2:  +1 973-660-8935

Tel.: +92 213 2200121-5
(Pakistan PCO Switchboard)

Tel.: +91 22 6693-2208
(India DSU Hot line Number)

Peru
Bolivia, Ecuador

PER.AEReporting@pfizer.com

Toll-Free (local): 08005-5181

Alt.1: +51 1 615-2314

Alt. 2:  +1 973-660-8945

Tel.: +51 1 615-2117 (24/7 ) 

Philippines

PHL.AEReporting@pfizer.com

Toll-Free (local): 18001110-1520

Alt. 1:  +1 973-660-8946

Adverse Event Reports:
Tel.: +63 2 451 9288 / +63 2 451 9200 loc.19904

Cell: +63 917 810 -8146

Poland

POL.AEReporting@pfizer.com

Toll-Free (local): 00800112-4454

Alt. 1:  +1 973-660-8947

Tel.: +48 22 335-6326

Portugal

PRT.AEReporting@pfizer.com

Toll-Free (local): 80082-7808

Alt. 1:  +1 973-660-8948

Tel.: +351 21 423-5523;

Cell: +351 91 661-4530
(Madaleno, Sandra)

Romania
Moldova

ROU.AEReporting@pfizer.com

Toll-Free (local): 80089-6200

Alt.1: +40 21 207-2806

Alt. 2:  +1 973-660-8949

Tel.: +40 724 25-1699;

Tel.: +40 730 01-7986

Russia
Belarus (See Belarus), Armenia, Azerbaijan, Georgia, Kazakhstan, Kyrgyzstan, Mongolia, Tajikistan, Turkmenistan, Uzebkistan

RUS.AEReporting@pfizer.com

Toll-Free (local): 8800100-6305

Alt. 1:  +1 973-660-8950

Tel.: +7 495 287-5000
(Pfizer switchboard, voice mail after office hours)

Tel.: +7 495 287-5343;

Cell: +7 985 222-6145
(Prokhorova, Tatyana)

Saudi Arabia

SAU.AEReporting@pfizer.com

Toll-Free (local): N/A

Alt.1:  N/A

Tel.: + 966 12 229-3633;

Cell: +966 53 906-9565
(Al Dhahri, Huda)

Serbia
Albania, Kosovo, Macedonia, Montenegro

SRB.AEReporting@pfizer.com

Toll-Free (local): N/A

Alt.1: +381 11 363-0026    Tel.: +381 11 363-0028

Cell: +381 63 50-9445
(Stojanovic, Branka)

Cell: +381 63 682 675
(Markovic Jelena)

Singapore

SGP.AEReporting@pfizer.com

Toll-Free (local): 800101-2817

Alt. 1:  +1 973-660-8951

Tel.: +65 6403-8888
(Pfizer switchboard)

Tel.: +65 9787-8028
(Safety Hotline Cell Phone for Pfizer internal colleagues)

Slovakia

SVK.AEReporting@pfizer.com

Toll-Free (local): 080060-6658

Alt. 1:  +1 973-660-8952

Tel.: +421 2 3355-5461 / +421 2 3355-5577

Cell: +421 905 96-2228/ +421 903 77-2805

Slovenia

SVN.AEReporting@pfizer.com

Toll-Free (local): 08008-1280

Alt. 1:  +1 973-660-8953

Tel.: +386 1 521-1400 (24hrs)

Tel.: +386 1 586-3232;

Cell: +386 40 18-8912
(Kastelec, Natasa)

Back-up contact n°s:
Tel.: +385 1 390-8788;

Cell: +385 91 370-7064
(Bacic, Julija)

South Africa
Botswana, Lesotho, Madagascar, Malawi, Mauritius, Mozambique, Namibia, Seychelles, Swaziland, Zambia, Zimbabwe

ZAF.AEReporting@pfizer.com

Toll-Free (local): 080099-9931

Alt.1:  +27 11 895-1600

Alt. 2:  +1 973-660-8961

Tel.:  0860 PFIZER (0860 734937)

Spain
Andorra

ESP.AEReporting@pfizer.com

Toll-Free (local): 90086-6211

Alt.1: +34 91 490-9705

Alt. 2:  +1 973-660-8925

Tel.: +34 91 490 9900 (Switchboard)

Sweden

SWE.AEReporting@pfizer.com

Toll-Free (local): 020091-0157

Alt. 1:  +1 973-660-8954

Tel.: +46 8 5505-2300

Switzerland
Liechtenstein

CHE.AEReporting@pfizer.com

Toll-Free (local): 080082-0047

Alt.1: +41 44 583-0757

Alt. 2:  +1 973-660-8918

Adverse Event Reports:
Tel.: +41 43 495-7299

Taiwan

TWN.AEReporting@pfizer.com

Toll-Free (local): 0080112-7411

Alt. 1:  +1 973-660-8957

Tel.:  0800-094-555
(24hrs, toll-free)

Tel.: +886 2 2809-7979

Cell: +886 937-471-979

Thailand
Cambodia, Laos, Myanmar
Vietnam  (See Vietnam)

THA.AEReporting@pfizer.com

Toll-Free (local): 1800156206-4512

Alt.1: +66 2 665-4966

Alt. 2:  +1 973-660-8955

Cell: +66 81 623-8429
(Safety Hotline Cell Phone)

Tunisia
Libya

TUN.AEReporting@pfizer.com

Toll-Free (local): N/A

Alt.1: +216 7196-2260

Tel.: +216 7116-9900
(Switchboard), 

+216 7116-9921
(Haddad, A.)

Cell: +216 20 19-9221
(Haddad, Abderrazak)

Turkey

TUR.AEReporting@pfizer.com

Toll-Free (local): 80014207-4598

Alt.1: +90 212 310-7072

Alt. 2:  +1 973-660-8956

Tel.: +90 212 310-7000
(Pfizer switchboard)

Ukraine

UKR.AEReporting@pfizer.com

Toll-Free (local): N/A

Alt.1: +38 044 391-6055

Tel.: +38 044 391-6050
(Pfizer switchboard)

Cell: +38 050 357-2198
(Uzlova, Irina);

+38 095 287-4676
(Kramarev, Oleksiy)

 

United Arab Emirates (UAE)
Bahrain, Iran, Kuwait, Oman, Qatar, Yemen (Gulf);
Iraq, Jordan,Lebanon,Syria (Levant)

ARE.AEReporting@pfizer.com

Toll-Free (local): 80003570-3237

Alt.1: +971 4 453-2435

Alt. 2:  +1 973-660-8911

Tel.: +971 4 453-2254; 

Cell: +971 5 6683-8653
(James, Agness)

United Kingdom
Channel Islands,  Isle of Man, Gibraltar
 Ireland (See Ireland)

GBR.AEReporting@pfizer.com

Toll-Free (local): 0800015-6401

Alt.1:  0845 300-8032

Alt. 2:  +1 973-660-8929

Tel.: 0845 300-8031

United States
American Samoa, Federated States of Micronesia, Guam, Midway Islands, Northern Mariana Islands, Puerto Rico, Republic of Palau, Republic of the Marshall Islands, U.S. and British Virgin Islands

USA.AEReporting@pfizer.com

(Non Clinical Trial reports)    Toll-Free (local): 1 866 635-8337
(Non Clinical Trial reports)

Toll-Free (local): 1 866 997-8322 (Clinical Trial, Compassionate Use , IIR reports)

Tel.: 800 438-1985 (toll-free)
(Non Clinical Trial reports)

Venezuela (under responsibility of  Colombia)

VEN.AEReporting@pfizer.com

Toll-Free (local): 0800134-1052

Alt. 1:  +1 973-660-8959

Cell: +57 318 280-4810
(24h line)

Vietnam (under responsibility of Thailand)

VNM.AEReporting@pfizer.com

Toll-Free (local): 1201-1469

Alt. 1:  +1 973-660-8960

Tel.: +84 966 98-0580
(Safety Hotline Cell Phone)

 

PP-GIP-GBR-1900 / April 2017